Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.

Wang H, Flannery SM, Dickhöfer S, Huhn S, George J, Kubarenko AV, Lascorz J, Bevier M, Willemsen J, Pichulik T, Schafmayer C, Binder M, Manoury B, Paludan SR, Alarcon-Riquelme M, Bowie AG, Försti A, Weber AN.

J Biol Chem. 2014 Aug 15;289(33):23123-31. doi: 10.1074/jbc.M113.492934. Epub 2014 Jun 19.

PMID:
24973222
2.

Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors.

Huhn S, Bevier M, Pardini B, Naccarati A, Vodickova L, Novotny J, Vodicka P, Hemminki K, Försti A.

Cancer Causes Control. 2014 Jun;25(6):759-69. doi: 10.1007/s10552-014-0379-1. Epub 2014 Apr 5.

PMID:
24706189
3.

Functional TLR5 genetic variants affect human colorectal cancer survival.

Klimosch SN, Försti A, Eckert J, Knezevic J, Bevier M, von Schönfels W, Heits N, Walter J, Hinz S, Lascorz J, Hampe J, Hartl D, Frick JS, Hemminki K, Schafmayer C, Weber AN.

Cancer Res. 2013 Dec 15;73(24):7232-42. doi: 10.1158/0008-5472.CAN-13-1746. Epub 2013 Oct 23.

4.

Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome.

Lu S, Bevier M, Huhn S, Sainz J, Lascorz J, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A.

Int J Cancer. 2013 Nov 15;133(10):2325-33. doi: 10.1002/ijc.28251. Epub 2013 May 29.

PMID:
23650115
5.

Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa.

Moumad K, Lascorz J, Bevier M, Khyatti M, Ennaji MM, Benider A, Huhn S, Lu S, Chouchane L, Corbex M, Hemminki K, Försti A.

G3 (Bethesda). 2013 Jun 21;3(6):971-7. doi: 10.1534/g3.112.005371.

6.

Influence of genetic variants in type I interferon genes on melanoma survival and therapy.

Lenci RE, Bevier M, Brandt A, Bermejo JL, Sucker A, Moll I, Planelles D, Requena C, Nagore E, Hemminki K, Schadendorf D, Kumar R.

PLoS One. 2012;7(11):e50692. doi: 10.1371/journal.pone.0050692. Epub 2012 Nov 27.

7.

Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases.

Huhn S, Bevier M, Rudolph A, Pardini B, Naccarati A, Hein R, Hoffmeister M, Vodickova L, Novotny J, Brenner H, Chang-Claude J, Hemminki K, Vodicka P, Försti A.

BMC Med Genet. 2012 Oct 5;13:94. doi: 10.1186/1471-2350-13-94.

8.

Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer.

Lascorz J, Bevier M, V Schönfels W, Kalthoff H, Aselmann H, Beckmann J, Egberts J, Buch S, Becker T, Schreiber S, Hampe J, Hemminki K, Schafmayer C, Försti A.

Int J Colorectal Dis. 2013 Feb;28(2):173-81. doi: 10.1007/s00384-012-1541-4. Epub 2012 Jul 28.

PMID:
23011546
9.

Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.

Hemminki K, Bevier M, Sundquist J, Hemminki A.

Int J Cancer. 2013 Feb 15;132(4):944-50. doi: 10.1002/ijc.27678. Epub 2012 Jul 21.

PMID:
22730111
10.

Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer.

Lascorz J, Bevier M, Schönfels WV, Kalthoff H, Aselmann H, Beckmann J, Egberts J, Buch S, Becker T, Schreiber S, Hampe J, Hemminki K, Försti A, Schafmayer C.

BMC Med Genet. 2012 Apr 30;13:31. doi: 10.1186/1471-2350-13-31.

11.

Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?

Hemminki K, Bevier M, Sundquist J, Hemminki A.

Ann Oncol. 2012 Oct;23(10):2720-4. Epub 2012 Apr 3.

12.

Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.

Bevier M, Sundquist J, Hemminki K.

Eur J Cancer Prev. 2012 Nov;21(6):596-601.

PMID:
22387673
13.

Risk of breast cancer in families of multiple affected women and men.

Bevier M, Sundquist K, Hemminki K.

Breast Cancer Res Treat. 2012 Apr;132(2):723-8. doi: 10.1007/s10549-011-1915-2. Epub 2011 Dec 17.

PMID:
22179927
14.

Survival in cancer of unknown primary site: population-based analysis by site and histology.

Hemminki K, Bevier M, Hemminki A, Sundquist J.

Ann Oncol. 2012 Jul;23(7):1854-63. doi: 10.1093/annonc/mdr536. Epub 2011 Nov 24.

15.

Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.

Shi H, Bevier M, Johansson R, Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P, Försti A.

Breast Cancer Res Treat. 2012 Feb;131(3):1039-47. doi: 10.1007/s10549-011-1826-2. Epub 2011 Oct 26.

PMID:
22037783
16.

Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.

Varadi V, Bevier M, Grzybowska E, Johansson R, Enquist-Olsson K, Henriksson R, Butkiewicz D, Pamula-Pilat J, Tecza K, Hemminki K, Lenner P, Försti A.

Breast Cancer Res Treat. 2012 Jan;131(1):311-9. doi: 10.1007/s10549-011-1765-y. Epub 2011 Sep 21.

PMID:
21935604
17.

Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters.

Ware B, Bevier M, Nishijima Y, Rogers S, Carnes CA, Lacombe VA.

Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1300-6. doi: 10.1152/ajpregu.00822.2010. Epub 2011 Aug 17.

18.

Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.

Shi H, Bevier M, Johansson R, Grzybowska E, Chen B, Eyfjörd JE, Hamann U, Manjer J, Enquist K, Henriksson R, Carlson J, Brandt A, Lascorz J, Butkiewicz D, Pamula-Pilat J, Tecza K, Herms S, Hoffmann P, Hemminki K, Lenner P, Försti A.

Breast Cancer Res Treat. 2011 Dec;130(3):905-16. doi: 10.1007/s10549-011-1600-5. Epub 2011 Jun 1.

PMID:
21630024
19.

Influence of family size and birth order on risk of cancer: a population-based study.

Bevier M, Weires M, Thomsen H, Sundquist J, Hemminki K.

BMC Cancer. 2011 May 9;11:163. doi: 10.1186/1471-2407-11-163.

20.

Polymorphisms in CTNNBL1 in relation to colorectal cancer with evolutionary implications.

Huhn S, Ingelfinger D, Bermejo JL, Bevier M, Pardini B, Naccarati A, Steinke V, Rahner N, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Pox CP, Goecke T, Kloor M, Loeffler M, Büttner R, Vodickova L, Novotny J, Demir K, Cruciat CM, Renneberg R, Huber W, Niehrs C, Boutros M, Propping P, Vodièka P, Hemminki K, Försti A.

Int J Mol Epidemiol Genet. 2011 Jan 1;2(1):36-50. Epub 2010 Nov 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk